pillbase.ru

capmatinib

Active substance: capmatinib

TABLET, FILM COATED · CAPMATINIB HYDROCHLORIDE 200 mg/1

United StatesActive

Marketing holder: Novartis Pharma Produktions GmbH

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Tabrecta
    capmatinib dihydrochloride monohydrate
    EMEA/H/C/004845
    Novartis Europharm Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-01a8-7f13-8245-61478a167e7e,01a12091-6a3c-7828-984b-bb390ce1338d,01a12093-4180-766c-bc45-c615ad47160e,01a12095-6cce-7e54-9f4b-0df186d7a146;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
66828-0275
Registration status
Active
Dispensing
Prescription only
Sources
  • product · openFDA NDC · 66828-0275 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 66828-0275 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 66828-0275 · Verified 2026-10-09 · open in source